Literature DB >> 28785187

AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2017.

Marc Thill1, Cornelia Liedtke2, Erich-Franz Solomayer3, Volkmar Müller4, Wolfgang Janni5, Marcus Schmidt6.   

Abstract

Entities:  

Keywords:  Local therapy; Metastatic breast cancer; Systemic therapy; Treatment recommendations

Year:  2017        PMID： 28785187      PMCID： PMC5527195          DOI： 10.1159/000477576

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  4 in total

1.  ABC4 Consensus: Assessment by a German Group of Experts.

Authors:  Nadia Harbeck; Diana Lüftner; Norbert Marschner; Michael Untch; Doris Augustin; Susanne Briest; Johannes Ettl; Renate Haidinger; Lothar Müller; Volkmar Müller; Eugen Ruckhäberle; Rachel Wuerstlein; Christoph Thomssen
Journal:  Breast Care (Basel)       Date:  2018-02-15       Impact factor: 2.860

2.  Can contemporary trials of chemotherapy for HER2-negative metastatic breast cancer detect overall survival benefit?

Authors:  Sherko Kümmel; Christian Jackisch; Volkmar Müller; Andreas Schneeweiss; Sandra Klawitter; Michael P Lux
Journal:  Cancer Manag Res       Date:  2018-11-08       Impact factor: 3.989

3.  The efficacy and safety of targeted therapy plus fulvestrant in postmenopausal women with hormone-receptor positive advanced breast cancer: A meta-analysis of randomized-control trials.

Authors:  Gao Chanchan; Su Xiangyu; Shi Fangfang; Chen Yan; Gu Xiaoyi
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

Review 4.  Surrogate threshold effect based on a meta-analysis for the predictive value of progression-free survival for overall survival in hormone receptor-positive, HER2-negative metastatic breast cancer.

Authors:  Michael Patrick Lux; Sarah Böhme; Stephanie Hücherig; Ulli Jeratsch; Niclas Kürschner; Diana Lüftner
Journal:  Breast Cancer Res Treat       Date:  2019-05-07       Impact factor: 4.624
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.